When diagnosing Pneumocystis jirovecii pneumonia (PJP), the clinical suspicion must be confirmed by laboratory tests. PJP is rarely described in patients with idiopathic CD4+ lymphocytopenia (ICL), a rare T‐cell deficiency of unknown origin with persistently low levels of CD4+ T‐cells (<300 µl−1 or <20 % of total lymphocytes) but repeated negative human immunodeficiency virus (HIV) tests. We retrospectively analysed a case of an ICL patient with severe PJP associated with multiple opportunistic infections (OIs). We also reviewed the literature since 1986.
Case presentation:
A laboratory‐confirmed case of PJP associated with invasive candidiasis and cytomegalovirus infection was reported in an ICL patient. Despite early treatment, the patient died of respiratory failure under polymicrobial pneumonia. According to the literature, the mortality rate of ICL patients is 10.4 % (33/316). In ICL patients, the risk of OI is 83.2 % (263/316), with viral infections being the most prevalent (58.2 %, 184/316), followed by fungal infections (52.2 %, 165/316) and mycobacterial infections (15.5 %, 49/316). Dysimmunity is reported in 15.5 % (49/316) of ICL patients. Among the fungal infections, cryptococcal infections are the most prevalent (24.1 %, 76/316), followed by candidiasis (15.5 %, 49/316) and PJP (7.9 %, 25/316).
Conclusions:
The high risk of OIs underlines the importance of more vigorous preventative actions in hospitals. The response to therapy and the detection of early relapse of PJP may be monitored by several laboratory tests including quantitative PCR. It is essential to treat the ICL and to follow the guidelines concerning therapy and prophylaxis of OIs as given to HIV patients.
CastroJ.G,
Morrison‐BryantM.
2010; Management of Pneumocystis jirovecii pneumonia in HIV infected patients: current options, challenges and future directions. HIV AIDS (Auckl) 2:123–134
ChumpitaziB.F.F,
FloriP,
KernJ‐B,
Brenier‐PinchartM‐P,
Hincky‐VitratV,
BrionJ‐P,
Thiebaut‐BertrandA‐T,
MinetC,
MaubonD.
other authors2011; Characteristics and clinical relevance of the quantitative touch‐down major‐surface‐glycoprotein polymerase chain reaction in the diagnosis of Pneumocystis pneumonia. Med Mycol 49:704–713
ChumpitaziB.F.F,
LebeauB,
Faure‐Cognet, Hamidfar‐RoyR,
TimsitJ.F,
PaveseP,
Thiebaut‐BertrandA,
QuesadaJ.L,
PellouxH.
other authors2014; Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis. Med Mycol 52:462–471[CrossRef]
ColombaC,
RubinoR,
Di CarloP,
MamminaC,
BonuraC,
SiracusaL,
TitoneL,
SaporitoL.
2012; Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report. J Med Case Rep 6:277[CrossRef]
CushionM.T,
StringerJ.R.
2010; Stealth and opportunism: alternative lifestyles of species in the fungal genus Pneumocystis
. Annu Rev Microbiol 64:431–452[CrossRef]
DenisB,
GuiguetM,
de CastroN,
MechaïF,
RevestM,
MahamatA,
GregoireG.M,
LortholaryO,
CostagliolaD.
2014; Critical importance of long‐term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004–2011 in the FHDH‐ANRS CO4 cohort. PLoS One 9:e94183[CrossRef]
DuncanR.A,
von ReynC.F,
AlliegroG.M,
ToossiZ,
SugarA.M,
LevitzS.M.
1993; Idiopathic CD4+ T‐lymphocytopenia – four patients with opportunistic infections and no evidence of HIV infection. N Engl J Med 328:393–398[CrossRef]
EstevesF,
MedranoF.J,
de ArmasY,
WissmannG,
CalderónE.J,
MatosO.
2014; Pneumocystis and pneumocystosis: first meeting of experts from Latin‐American and Portuguese‐speaking countries – a mini‐review. Expert Rev Anti Infect Ther 12:545–548[CrossRef]
Fricker‐HidalgoH,
LebeauB,
PellouxH,
GrillotR.
2004; Use of the BACTEC 9240 System with Mycosis‐IC/F blood culture bottles for detection of fungemia. J Clin Microbiol 42:1855–1856[CrossRef]
MarukutiraT,
HuprikarS,
AzieN,
QuanS.P,
Meier‐KriescheH.U,
HornD.L.
2014; Clinical characteristics and outcomes in 303 HIV‐infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. HIV AIDS (Auckl) 6:39–47[CrossRef]
MasurH,
BrooksJ.T,
BensonC.A,
HolmesK.K,
PauA.K,
KaplanJ.E.
2014; Prevention and treatment of opportunistic infections in HIV‐infected adults and adolescents: updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 58:1308–1311[CrossRef]
MatsuyamaW,
TsurukawaT,
IwamiF,
WakimotoJ,
MizoguchiA,
KawabataM,
OsameM.
1998; Two cases of idiopathic CD4+ T‐lymphocytopenia in elderly patients. Intern Med 37:891–895[CrossRef]
McBathA,
StaffordR,
AntonyS.J.
2014; Idiopathic CD4 lymphopenia associated with neuroinvasive West Nile disease: case report and review of the literature. J Infect Public Health 7:170–173[CrossRef]
Ollé‐GoigJ.E,
RamírezJ,
CerveraC,
MiróJ.M.
2012; Profound reduction of CD4+ lymphocytes without HIV infection: two cases from the horn of Africa. Afr Health Sci 12:331–333
RégentA,
KlugerN,
BéreznéA,
LassouedK,
MouthonL.
2012; Démarche diagnostique devant une lymphopénie: quand penser à la lymphopénie CD4+ idiopathique?. Rev Med Interne 33:628–634[CrossRef]
RouxA,
GonzalezF,
RouxM,
MehradM,
MenottiJ,
ZaharJ.R,
TadrosV.X,
AzoulayE,
BrilletP.Y.
other authors2014; Update on pulmonary Pneumocystis jirovecii infection in non‐HIV patients. Med Mal Infect 44:185–198[CrossRef]
SageE.K,
NoursadeghiM,
EvansH.E,
ParkerS.J,
CopasA.J,
EdwardsS.G,
MillerR.F.
2010; Prognostic value of C‐reactive protein in HIV‐infected patients with Pneumocystis jirovecii pneumonia. Int J STD AIDS 21:288–292[CrossRef]
SiniccoA,
MaielloA,
RaiteriR,
SciandraM,
DassioG,
ZamprognaC,
MecozziB.
1996; Pneumocystis carinii in a patient with pulmonary sarcoidosis and idiopathic CD4+ T lymphocytopenia. Thorax 51:446–447[CrossRef]
SmithD.K,
NealJ.J,
HolmbergS.D.
1993; Unexplained opportunistic infections and CD4+ T‐lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T‐lymphocytopenia Task Force. N Engl J Med 328:373–379[CrossRef]
ThodenJ,
PotthoffA,
BognerJ.R,
BrockmeyerN.H,
EsserS,
Grabmeier‐PfistershammerK,
HaasB,
HahnK,
HärterG.
other authors2013; Therapy and prophylaxis of opportunistic infections in HIV‐infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). Infection 41:(Suppl.2)S91–S115[CrossRef]
TuG.W,
JuM.J,
XuM,
RongR.M,
HeY.Z,
XueZ.G,
ZhuT.Y,
LuoZ.
2013; Combination of caspofungin and low‐dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients. Nephrology (Carlton) 18:736–742[CrossRef]
VenzorJ,
HuaQ,
BresslerR.B,
MirandaC.H,
HustonD.P.
1997; Behçet’s‐like syndrome associated with idiopathic CD4+ T‐lymphocytopenia, opportunistic infections, and a large population of TCRαβ+ CD4− CD8− T cells. Am J Med Sci 313:236–238[CrossRef]
WalzerP.D.
2013; The ecology of Pneumocystis: perspectives, personal recollections, and future research opportunities. J Eukaryot Microbiol 60:634–645[CrossRef]
ZoniosD,
SheikhV,
SeretiI.
2012; Idiopathic CD4 lymphocytopenia: a case of missing, wandering or ineffective T cells. Arthritis Res Ther 14:222[CrossRef]